By Dave Simpson ( December 9, 2022, 9:49 PM EST) -- The Third Circuit affirmed a lower court decision nixing allegations from Zydus Pharmaceuticals Inc. that Takeda Pharmaceutical Co. used sham patent litigation to delay generic competition for its heartburn medication Prevacid, ruling Friday that the litigation was not objectively baseless....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.